Clinical factors associated with augmentation treatment with second-generation antipsychotics and lithium in major depression – Results from a European multicenter study-Reference-Cited by-同舟云学术

Clinical factors associated with augmentation treatment with second-generation antipsychotics and lithium in major depression – Results from a European multicenter study

Published:2018-12 Issue:12 Volume:28 Page:1305-1313
ISSN:0924-977X
Container-title:European Neuropsychopharmacology
language:en
Short-container-title:European Neuropsychopharmacology

Author:

Dold Markus^ORCID,Bartova Lucie^ORCID,Kautzky Alexander,Serretti Alessandro^ORCID,Porcelli Stefano,Souery Daniel,Mendlewicz Julien,Montgomery Stuart,Zohar Joseph,Kasper Siegfried

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology,Pharmacology

Reference30 articles.

1. APA, 2010. Practice Guideline for the Treatment of Patients with Major Depressive Disorder. third ed. American Psychiatric Association (APA), Arlington (VA).

2. Role of lithium augmentation in the management of major depressive disorder;Bauer;CNS Drugs,2014

3. Extended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorder;Bauer;J. Affect. Disord.,2013

4. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders;Bauer;World J. Biol. Psychiatry,2013

5. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis;Cipriani;BMJ,2013

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The clinical perspective on late-onset depression in European real-world treatment settings;European Neuropsychopharmacology;2024-07

2. Psychiatric and legal considerations for ketamine treatment within prison settings;Frontiers in Psychiatry;2024-04-18

3. New Advances in the Pharmacology and Toxicology of Lithium: A Neurobiologically Oriented Overview;Pharmacological Reviews;2024-02-08

4. Brexpiprazole versus placebo or other antidepressive agents for treating depression;Cochrane Database of Systematic Reviews;2023-07-28

5. Characterisation of medication side effects in patients with mostly resistant depression in a real-world setting;The World Journal of Biological Psychiatry;2022-11-11